Tickerplace logo

Tickerplace

Neumora Therapeutics, Inc. Common Stock logo

NMRANeumora Therapeutics, Inc. Common Stock

NMRA Stock Price, Valuation & Chart | Neumora Therapeutics, Inc. Common Stock

Compare
$1.380+0.05 (+3.76%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyNMRA intrinsic valueNMRA calculated fair value vs price
OverviewFinancialsDividendsRatios

NMRA Historical price chart

NMRA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization255.69M
PE Ratio-1.12
EPS-1.23
Trading Volume532.23K
Today's High/Low1.41/1.35
Dividend Yield0.00
52 Week High/Low3.65/0.83
Shares Outstanding185.28M
NMRA Financial Statement
NMRA Analyst ratings
NMRA Analysis & performance metrics

NMRA Company profile

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and…

NMRA Management team

Management
Jason G. Duncan J.D.
Chief Legal & Administrative Officer
Nicholas Brandon Ph.D.
Chief Scientific Officer
Rajesh Manchanda Ph.D.
Chief Technical Operations Officer
Amy Sullivan
Chief Human Resources Officer
Maryjo Chamberlain-Tharp Ph.D.
Chief Business Officer
Lori Houle
Chief Quality Officer
Joshua Pinto Ph.D.
President
Michael Lee MilliganCFO
Chief Financial Officer & Principal Accounting Officer
Total 8 executives

NMRA Frequently asked questions

What is Neumora Therapeutics, Inc. Common Stock (NMRA) Stock Price?

Current stock price of Neumora Therapeutics, Inc. Common Stock (NMRA) stock is $1.380. The stock price is +3.76% higher in the session. The intraday range can be seen from this page. Volume of Neumora Therapeutics, Inc. Common Stock (NMRA) stock is 532.23K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Neumora Therapeutics, Inc. Common Stock (NMRA) stock price going up or down today?

The stock price of Neumora Therapeutics, Inc. Common Stock (NMRA) can change with earnings, company news, and overall market sentiment. Neumora Therapeutics, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Neumora Therapeutics, Inc. Common Stock stock expensive at its current price?

Whether Neumora Therapeutics, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NMRA on this page is -1.12. EPS on this page is -1.23. Compare those figures with peers and growth expectations before deciding if the current Neumora Therapeutics, Inc. Common Stock price is justified.

How has the stock price of Neumora Therapeutics, Inc. Common Stock (NMRA) performed historically?

Historical performance for Neumora Therapeutics, Inc. Common Stock (NMRA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NMRA reacted to past earnings and market events.

Should I buy Neumora Therapeutics, Inc. Common Stock (NMRA) stock, at this price?

Buying Neumora Therapeutics, Inc. Common Stock (NMRA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.